Form 8-K Bausch Health Companies For: Nov 03
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher as Fed holds key rate steady, focus turns to earnings
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise on Yemen fighting, Saudi refinery attack
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
- ServiceNow (NOW) Misses Q3 EPS by 2c, Beats on Revenue; Offers Q4 Revenue Guidance
- Oracle sets $225 billion revenue target for FY30 at investor day
- Rivian shares slip ahead of Thursday earnings release
- Marvell in advanced talks to acquire Lumentum, Bloomberg reports
- S&P Global explores potential separation of Capital IQ business
Bausch Health Companies (BHC) PT Lowered to $14 at Stifel
November 3, 2022 1:23 PM EDTStifel analyst Annabel Samimy lowered the price target on Bausch Health Companies (NYSE: BHC) to $14.00 (from $15.00) while maintaining a Buy rating following results.
The analyst commented, "Remaining committed to the BLCO separation, BHC reported a lower 3Q22, with revenues of $2,046mn/Cons.... More
Bausch Health Companies (BHC) PT Lowered to $35 at Cowen
November 3, 2022 11:45 AM EDTCowen analyst Ken Cacciatore lowered the price target on Bausch Health Companies (NYSE: BHC) to $35.00 (from $40.00) while maintaining a Outperform rating following results.
The analyst commented, "Q3 revs reached $2.05B, in line, driven by recovery in all major segments including Salix, Solta, and... More



